Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
doi:10.2147/DMSO.S312527 16
Dette har isr betydning ved behandling med GLP-1-analoger
Men dealing with brain fog, fatigue, or feeling toxic often notice significant improvement with glutathione therapy
While some people prefer to take their injections in the morning, I personally find that taking the shot before bed works best for me